Phase 2 Study of MGL-3196 in Patients With Non-Alcoholic Steatohepatitis (NASH)
Clinical trial NCT02912260 · COMPLETED
Trial details
- NCT number
- NCT02912260
- Sponsor
- Madrigal Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-18
- Primary completion
- 2017-10-25
- Enrollment
- 125
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.